Xencor to Present at the Piper Sandler 35th Annual Healthcare Conference
21 Novembre 2023 - 10:01PM
Business Wire
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical
company developing engineered antibodies and cytokines for the
treatment of patients with cancer and autoimmune diseases, today
announced that company management will present at the Piper Sandler
35th Annual Healthcare Conference in New York City on Tuesday,
November 28, 2023, at 8:00 a.m. ET / 11:00 a.m. PT.
A live webcast of the presentation will be available under
"Events & Presentations" in the Investors section of the
Company's website located at www.xencor.com. After the webcast, a
replay will be archived on the website for at least 30 days.
About Xencor
Xencor is a clinical-stage biopharmaceutical company developing
engineered antibodies and cytokines for the treatment of patients
with cancer and autoimmune diseases. More than 20 candidates
engineered with Xencor's XmAb® technology are in clinical
development, and three XmAb medicines are marketed by partners.
Xencor's XmAb engineering technology enables small changes to a
protein's structure that result in new mechanisms of therapeutic
action. For more information, please visit www.xencor.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231121433378/en/
Charles Liles cliles@xencor.com 626-737-8118
Grafico Azioni Xencor (NASDAQ:XNCR)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Xencor (NASDAQ:XNCR)
Storico
Da Mag 2023 a Mag 2024